Monoclonal antibody therapy is for the treatment of COVID-19 in non-hospitalized patients who have mild to moderate COVID-19 symptoms, and who are at high risk of progressing to severe symptoms and/or hospitalization. Monoclonal antibody therapies became available under FDA Emergency Use Authorization.
Contact your primary care provider or an urgent care if you feel you qualify for this therapy.
For more information, please visit the New Mexico Department of Health
If you are having life-threatening symptoms, please call 911 or go to the emergency department.